Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ascalon International
AddedFeb 18, 2024
UpdatedJun 18, 2026
Ascalon International

Ascalon International

Closed

Oncology-focused Ascalon International develops drugs, conducts biomarker-based trials, and forms strategic alliances.

HQ
Scottsdale, AZ, US
Founded
2009
Overview
Compare
Fundraising
Employees

Ascalon International, Inc., an oncology drug development company, creates and manages a portfolio of oncology drugs. The company also conducts biomarker-based clinical trials in oncology.

In addition, it focuses on developing products by clinical development and regulatory execution, either by establishment of a joint development with the product owner or by acquisition of the product. The company has a strategic and operational alliance with Parexel. Ascalon International, Inc. was founded in 2009 and is based in Scottsdale, Arizona.

Ascalon International - Similar Companies

Ascenta Therapeutics logo

Ascenta Therapeutics

Panacela Labs logo

Panacela Labs

panacelalabs.com

Oncolix logo

Oncolix

Champions Oncology logo

Champions Oncology

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

Clovis Oncology logo

Clovis Oncology

Asylia Therapeutics logo

Asylia Therapeutics

asyliatx.com

OncoResponse logo

OncoResponse

Accelerated Pharma logo

Accelerated Pharma

Cullinan Oncology logo

Cullinan Oncology

Akelos logo

Akelos

akelosinc.com

Strata Oncology logo

Strata Oncology

strataoncology.com

Ascent Therapeutics logo

Ascent Therapeutics

Curelab Oncology logo

Curelab Oncology

Oncoholdings logo

Oncoholdings

Ascalon International - Quick Facts

Who are Ascalon International's competitors?

Companies similar to Ascalon International include Ascenta Therapeutics, Panacela Labs, Oncolix and Champions Oncology.

When was Ascalon International founded?

Ascalon International was founded in 2009.

Where is Ascalon International's headquarters located?

Ascalon International's headquarters is located in Scottsdale, AZ, US.

When was Ascalon International's last funding round?

Ascalon International's most recent funding round was for $100k (USD) in December 2011.

How much has Ascalon International raised to-date?

As of Dec 8, 2011, Ascalon International has raised a total of $905.3k (USD).

Ascalon International - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Clinical Trials
  • Oncology Drugs
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified